Your Top 50 most-cited badge
A badge for your website, a sentence for your CV, and a permanent page where anyone can check the rank.
The article
A phase I dose escalation and expansion trial of the next-generation oral SERD camizestrant in women with ER-positive, HER2-negative advanced breast cancer: SERENA-1 monotherapy results
E. Hamilton, Mafalda Oliveira, Nicholas C. Turner, J. García-Corbacho, Cristina Hernándo, Eva Ciruelos and 15 more
- Rank
- 37 of 3,853
- Percentile
- top 1%
- Where
- Annals of Oncology, 2024
- Citations
- 70
From the 2024 list, OpenAlex counts as of 2026-10-29.
Prefer not to be listed? The same link lets you withhold your name on every list; the article stays, your name does not. Questions: team@avidnote.com.